Recent Articles from Investor Brand Network

NeoVolta (NASDAQ: NEOV), a U.S.-based energy technology company focused on scalable energy storage solutions, announced that CEO Ardes Johnson will present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference taking place Sept. 9–10 in New York City. Johnson is slated to deliver an in-person investor presentation at 4:05 p.m. ET on Sept. 9, while company management will also hold one-on-one meetings with investors. NeoVolta develops innovative energy storage solutions for home, business, and utility applications.

Disseminated on behalf of NurExone Biologic Inc. (TSX.V NRX) (OTCQB:NRXBF) and may include paid advertising.

SS Innovations International (NASDAQ: SSII) was highlighted in a Seeking Alpha analysis comparing the company with Intuitive Surgical, Inc. (NASDAQ: ISRG) in the expanding surgical robotics market. The analysis cited SS Innovations growth trajectory, emerging-market positioning and lower-cost SSi Mantra surgical robotic platform, noting that its installed base increased 187% from 78 systems at the end of Q1 FY25 to 224 in Q2 FY26, while Q2 revenue increased 39% year over year.

Prospect Markets (TSX.V: MKT) (OTCQB: MKTSF) (FSE: DEP) announced that its indirect wholly owned subsidiary, Prospect Brokerage USA LLC, executed a definitive agreement with OG Prediction Markets and Crypto.com | Derivatives North America to launch an event-based prediction markets offering initially in the United States. The agreement enables Prospect Brokerage to offer event contracts through Crypto.com regulated infrastructure and advances Prospect planned U.S. launch ahead of the upcoming NFL and NBA seasons. The broader prediction markets sector is projected by Bernstein to reach approximately $240 billion in trading volume in 2026 and approximately $1 trillion annually by 2030.

According to media reports, Anthropic has signed a deal worth $45 billion with UK-based firm Nscale. The deal entails the AI infrastructure company providing AI compute capacity of 460 megawatts to Anthropic starting in 2027.

As GLP-1 use has exploded in the U.S., many companies have started discontinuing coverage of these treatments in the health plans they maintain for their employees. This is a trend worth watching, and it warrants a deeper look to understand why it is happening .

A financing gap is putting clean energy investment at risk, even as capital floods into the sector at record levels. Capital in private markets is increasingly split between two extremes. Plentiful venture funding chases early-stage startups on one side. At the same time, a deep reservoir of pension- and insurance-style money seeks out established assets with predictable earnings and long track records.

Olenox Industries (NASDAQ: OLOX) announced it is moving its previously announced North Texas multi-well oil and natural gas development program into field execution, with seismic work expected to begin the week of Sept. 7, 2026. The company has engaged a seismic services firm and added geological and engineering expertise to evaluate 10 potential drill sites, with fieldwork expected to take approximately two to three weeks.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

Datavault AI (NASDAQ: DVLT) announced it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place Sept. 9-10, 2026, in New York City. Chairman and Chief Financial Officer Brett Moyer will deliver an investor presentation and participate in scheduled one-on-one meetings with investors.

Global electricity access is expanding at a record pace, yet the number of people still living without power globally has barely budged . New analysis tracking progress toward universal electricity access found that roughly 89 million people got new access to power in 2024, though the total global shortfall edged down by just 11.5 million, the smallest yearly improvement on record going back to 2010, aside from a brief bump in 2022. As of 2024, some 655 million people still lack access to electricity.

Gold is showing a fresh technical warning after climbing above $4,750 an ounce as the latest surge indicates that the market’s momentum could be reaching stretched levels. Although the metal’s overall recovery remains strong, the rapid pace of gains has made the outlook more challenging for investors.

From the end of July to August 25, the price of silver appreciated by 19%. During that same timeframe, the price of gold recorded gains of 15.1%. However, all the attention is going to gold’s performance, while silver is barely being mentioned even though it did the heavy lifting for precious metals.

Germany has strengthened its position as Europe’s leading hub for regulated crypto services after six banks received authorization under the European Union’s Markets in Crypto Assets (MiCA) framework.

Kia is putting a genuinely affordable electric vehicle on the American market at a moment when almost no other automaker is bothering to try. The EV3, a compact crossover, starts at $31,385 with roughly 220 miles of range, a price point that has become nearly impossible to find in the U.S. as new EV launches cluster toward the premium end of the market.

Crypto traders are heading into another closely watched session after Bitcoin briefly moved above $80,000 earlier last week, only to retreat toward $78,000. Attention is now turning to core PCE inflation figures and Nvidia’s quarterly results, with both events expected to influence broader market sentiment in the wake of the Jackson Hole gathering.

Hyundai is preparing to accelerate its electric vehicle (EV) expansion by relying on new battery technology that promises higher output, faster charging and lower costs. The South Korean automaker wants electrified vehicles to account for 60% of its global sales by 2030, a major increase from the 23% recorded last year.

Nvidia has delivered another blockbuster quarter, with sales and profits far exceeding Wall Street estimates as demand for the processors used to build artificial intelligence systems continues to climb.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

CNS Pharmaceuticals (NASDAQ: CNSP) announced its participation in a Virtual Investor “What This Means” segment featuring Chief Business Officer Dylan Wenke. Wenke discussed the company strategy to build a pipeline focused on oncology or neurology with best-in-class potential, including its approach to identifying and evaluating potential in-licensing and acquisition opportunities based on scientific, clinical, regulatory and commercial criteria. He also outlined CNS Pharmaceuticals business development process and near-term priorities as the company continues pursuing opportunities it believes could create long-term shareholder value.

Whether you’re in the military, law enforcement, riot control, or other loud, chaotic, and potentially-dangerous industries, the ability to communicate with your team effectively, while also protecting your hearing, is critical. To address this growing need, Silynxcom Ltd. (NYSE American: SYNX) has developed exceptional in-ear tactical communication systems.

Rezolve Ai (NASDAQ: RZLV) reported revenue of $130.8 million for the six months ended June 30, 2026, up approximately 1,970% from $6.3 million in the prior-year period, while its customer base expanded to more than 1,640 from more than 950 at year-end 2025. Gross profit increased to $63.9 million from $6 million, with a gross margin of 48.9%. The company highlighted its partner-led distribution relationships with Microsoft, Google, Tata Consultancy Services and Tech Mahindra, as well as Google’s deployment of Rezolve proprietary distributed database technology within Google Cloud. Rezolve reaffirmed its expectation of approximately $360 million in fiscal 2026 revenue and its target of at least $500 million in annual recurring revenue as it exits the year.

American Fusion (OTC: AMFN) announced the publication of an updated equity research report by Harbinger Research, LLC examining the company’s progress since initial coverage in January 2026. Titled “Advancing Modular Fusion Power Toward Commercial Validation,” the report reviews American Fusion’s transition into active testing of its 5 MW pre-production Texatron(TM) Fusion Engine(TM) at Texas Tech University, expansion to 100 pending U.S. patent applications, advancement to the OTCQB Venture Market and development of its scientific and engineering organization. Harbinger also identifies potential future catalysts including additional testing results, evidence of D–3He fusion, quantitative energy and power-output measurements, independent validation, commercial agreements and progress toward a national-exchange listing.

BOXABL (NASDAQ: BXBL) Co-Founder and Co-CEO Galiano Tiramani joined IBN’s Bell2Bell Podcast to discuss the company modular building system, manufacturing strategy and plans to scale housing production. Tiramani highlighted BOXABL’s approach to applying assembly-line mass production to housing, its shipping model designed to expand the reach of centralized manufacturing and its 400,000 square feet of manufacturing space. He also discussed the company shift from a heavy focus on research and engineering toward sales and deployment, including the planned rollout of its Phase Two product lineup, as well as BOXABL’s Nasdaq listing, vertical integration plans and long-term growth strategy.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

Frontieras North America and Western Fuels entered into a memorandum of understanding (“MOU”) to jointly develop a mine-mouth FASForm(TM) processing facility at the Dry Fork Mine near Gillette, Wyoming. The MOU contemplates long-term agreements covering a facility site, coal feedstock supply of up to approximately 2.7 million tons annually initially and 5.4 million tons at full build-out, Western Fuels purchases of ultra-low-sulfur diesel produced at the facility and potential use of Western Fuels Association transportation capabilities to move FASForm(TM) product streams.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Streaming apps shuffle through millions of songs in seconds, yet almost nobody asks who is actually protecting the original master recordings once the algorithm moves on. HWAL (OTC: HWAL) is a holding company built around that exact question.

BOXABL (NASDAQ: BXBL) announced a multiyear purchase agreement with LC Vegas Acquisitions, LLC contemplating the purchase of up to 1,500 BOXABL homes over three years, representing the company largest announced residential purchase arrangement to date. Purchases are expected to occur in phases at approximately 500 homes annually, subject to project schedules, site readiness, regulatory approvals and other conditions. The agreement does not require any purchases to be made and contemplated units may be modified, delayed, reduced or terminated under its terms.

Market Street Capital was featured in a recent article that discussed its positioning amid challenges facing first-of-a-kind (“FOAK”) energy projects, which often struggle to secure conventional project financing because they lack a commercial operating track record and carry greater technology, construction and performance risks. The piece explains how sponsors can bridge this “bankability gap” through layered capital structures combining senior debt, mezzanine financing, tax equity, offtake-backed financing, sponsor equity and government support, with careful coordination of covenants, waterfalls and intercreditor agreements. It identifies creditworthy offtake counterparties, independent technical due diligence, completion and performance guarantees, diversified risk allocation and government participation as factors that can improve finance ability.

Disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

The rapid growth of artificial intelligence (AI) is changing the way the United States produces electricity. As technology companies race to build large data centers capable of supporting AI systems, demand for reliable power has increased sharply. This has encouraged a major expansion of gas-fired power projects across the country.

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage developer of broad-spectrum antivirals based on host-mimetic nanomedicine technology, provided an update on its NV-387 measles treatment program as measles cases continue to rise in the U.S. and globally. The company is developing a Phase II clinical trial protocol to evaluate NV-387 as a treatment for measles and intends to bring the protocol under U.S. Food and Drug Administration (“FDA”) review through an Investigational New Drug (“IND”) process. NanoViricides said NV-387 has demonstrated strong in vivo activity against lethal measles infection in a humanized animal model and has received both Orphan Drug Designation (“ODD”) and Rare Pediatric Disease Drug (“RPDD”) Designation from the FDA for the treatment of measles. The RPDD designation could make the company eligible for a Priority Review Voucher upon approval of a qualifying marketing application, provided applicable requirements are met.

TransCode Therapeutics (NASDAQ: RNAZ) a clinical-stage company developing immuno-oncology and RNA-based therapeutics for high-risk and advanced cancers, announced publication of a peer-reviewed article in Cancers reporting preclinical results for its lead therapeutic candidate, TTX-MC138, in a model of breast cancer bone metastasis. The study found that TTX-MC138 accumulated in metastatic bone lesions following systemic administration, reduced expression of microRNA-10b (“miR-10b”), increased expression of the downstream tumor-suppressor target HOXD10 and produced significant survival benefits compared with controls. Repeated dosing was well tolerated with no observed systemic toxicity. The findings further support TransCode’s approach of inhibiting miR-10b using its proprietary oligonucleotide nanotechnology and suggest potential applicability across additional metastatic disease settings.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.

Rezolve Ai (NASDAQ: RZLV), a provider of agentic commerce and AI-powered retail infrastructure, and Tech Mahindra Limited (NSE: TECHM), a global provider of technology consulting and digital solutions, announced a strategic alliance to accelerate deployment of agentic commerce across large enterprises worldwide. The collaboration combines Rezolve Ai’s purpose-built Brain Suite with Tech Mahindra’s consulting, systems integration, cloud, data and global delivery capabilities, targeting retail, consumer goods, financial services and other transaction-intensive industries. The companies intend to help enterprises move AI from pilots and customer-service applications into production environments capable of understanding customer intent, recommending products and completing transactions.

Wrap Technologies (NASDAQ: WRAP) is featured in a new NetworkNewsAudio Audio Press Release (APR) titled “The Interception Gap: Directed Energy Solved Cost of Shooting Down Drones, Exposed a Harder Problem Underneath.” The editorial examines how drones that do not rely on radio-frequency signals are challenging conventional RF-based detection and jamming systems and highlights Wrap Technologies passive, physics-based sensing approach. Through an exclusive U.S. and NATO license from Israeli firm Frenel Imaging, the company is commercializing the technology under its WrapShield architecture, which is designed to detect drones based on their material signatures rather than emitted radio signals.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Oragenics (NYSE American: OGEN), a clinical-stage biopharmaceutical company developing brain-targeted therapeutics through its proprietary intranasal delivery platform, provided updates on its Phase IIa feasibility trial of ONP-002 for mild traumatic brain injury (“mTBI”), its U.S. regulatory pathway and NYSE American continued listing status. The company has dosed nine participants across three active Australian clinical sites — Alfred Health, Mackay and Royal Adelaide Hospital — and has received responses from the U.S. Food and Drug Administration (“FDA”) related to its Type B meeting request briefing package submitted in July 2026. Oragenics is reviewing the FDA responses and remains focused on submitting an Investigational New Drug (“IND”) application by the end of 2026.

Xeriant (OTCQB: XERI) announced it is initiating production of NexBoard(TM), its patented and certified universal construction panel, through a contract manufacturer capable of supporting high-volume commercial output. The production campaign will allow Xeriant to fulfill sample requests from homebuilders and commercial construction firms and follows independent third-party testing in which NexBoard achieved a Class A rating under ASTM E84 and passed the NFPA 286 corner room burn test. Made from recycled plastic and fiber waste and incorporating Xeriant proprietary Durazite(TM) fire-retardant technology under the DUREVER(TM) brand, NexBoard is designed for applications including interior walls and ceilings, subflooring, roofing underlayment and exterior sheathing.

Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, recently acquired Zoolzy LLC. Based in Doral, Florida, where it operates from a 3,684-square-foot facility, Zoolzy is a wholesale distributor of active pharmaceutical ingredients (“APIs”) and finished FDA-approved prescription products ( https://ibn.fm/vcqkE ).

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

SS Innovations International (NASDAQ: SSII) is expanding its presence in the growing global robotic surgery market through its proprietary SSi Mantra surgical robotics platform, with a strategy focused on advanced technology, affordability, physician training, and international expansion. The company reports that more than 200 SSi Mantra systems have been installed worldwide, supporting over 12,000 robotic procedures across more than 170 surgical indications, including more than 650 cardiac procedures and more than 170 telesurgeries. SS Innovations is also investing in physician education through its international robotics training program, while pursuing U.S. FDA clearance and European regulatory approvals. Looking ahead, the company is exploring applications involving artificial intelligence, advanced imaging, specialty-specific robotics, pediatric surgery, mobile operating units, and military and disaster-response environments as demand for minimally invasive surgical technologies continues to grow.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

MindWave Innovations (NYSE American: APUS) is positioning its planned MindChain blockchain infrastructure to capitalize on the growing real-world asset (“RWA”) tokenization market as tokenized Treasuries, private credit, commodities, and other traditional assets move toward broader institutional use. MindChain is designed as an Ethereum-compatible Layer 2 with an insurance-oriented architecture and dedicated subnetworks for industries including real-world assets, insurance, AdTech, and ClimateTech, with an initial RWA focus on real estate and commodities. The company expects the network to launch in October 2026, following a testnet period and security audit, with its NILA token intended to serve as the network’s native asset. As institutional adoption increasingly shifts from simply tokenizing assets toward using them for trading, lending, collateral, and other financial applications, MindWave is seeking to differentiate MindChain through scalability, interoperability, predictable economics, and additional risk-mitigation infrastructure.

AmpliTech Group (NASDAQ: AMPG, AMPGZ) will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York City on Sept. 9–10, 2026. Founder, Chairman, President and CEO Fawad Maqbool will deliver an investor presentation at 2:10 p.m. ET on Sept. 9 and participate in scheduled one-on-one investor meetings. AmpliTech develops and manufactures advanced RF and microwave components and systems that enable next-gen connectivity and communication.

Millennial Potash Corp. will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York City taking place on Sept. 9–10, 2026. Senior management will deliver an investor presentation and hold scheduled one-on-one meetings with investors during the two-day event. The conference will bring together growth companies, investors, executives, and industry professionals through presentations, investor meetings, fireside chats, capital markets panels, and networking opportunities.

GPO Plus+ (OTCQB: GPOX) Chairman and CEO Brett H. Pojunis will present the company’s AI-powered Direct Store Delivery (“DSD”) growth strategy at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York on Sept. 10, 2026. Pojunis will highlight the company’s proprietary PRISM+ technology platform, Hub model, operating traction, market opportunity, and roadmap toward a leading nationwide DSD network. The presentation will be followed by a live Q&A, giving investors an opportunity to learn more about the company’s technology-driven distribution model and expansion strategy.

NeoVolta (NASDAQ: NEOV), a U.S.-based energy technology company focused on scalable energy storage, will present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York City on Sept. 9–10, 2026. CEO Ardes Johnson is scheduled to deliver an in-person investor presentation at 4:05 p.m. ET on Sept. 9, with management also available for one-on-one investor meetings. According to the announcement, NeoVolta is focused on developing reliable, high-performance energy storage solutions for residential, commercial, and utility applications.

WhiteFiber (NASDAQ: WYFI) announced the closing of its previously announced upsized private placement of $310 million principal amount of 5% convertible senior notes due 2032, including the full exercise of the initial purchasers’ $40 million option. The company received approximately $298.5 million in net proceeds, using approximately $118.5 million for concurrent transactions that exchanged $198.15 million of existing convertible notes for cash and approximately 6.3 million ordinary shares. WhiteFiber expects to use the remaining proceeds primarily for data center expansion, including additional properties, facility construction, energy service agreements, GPU servers and potential acquisitions, partnerships and joint ventures, as well as working capital and general corporate purposes. The financing supports WhiteFiber plans to advance its development pipeline, including its target of bringing more than 100 MW of additional capacity online in 2027.

U.S. Gold Corp. (NASDAQ: USAU) will present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York on Sept. 9–10, 2026. Chairman Luke Norman is scheduled to present at 11:05 a.m. ET on Sept. 9 and will also hold in-person one-on-one meetings during the conference. The presentation will be webcast through the conference website. U.S. Gold Corp. is a U.S.-focused gold and copper exploration and development company with projects in Wyoming, Nevada, and Idaho.

M2i Global (OTCQB: MTWO) will present at the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference on Sept. 9–10 at The Westin New York Grand Central. The company will highlight its work in domestic critical mineral recovery, recycling, processing, and repository development while connecting with investors in New York. Attendees interested in meeting with M2i are encouraged to reach out to schedule time.

Moody Capital chose IBN (“InvestorBrandNetwork”) to serve as an official media partner for the 2026 Disruptive Growth and Life Sciences Conference, taking place Sept. 9-10, 2026, at The Westin New York Grand Central in New York City. The conference will bring together companies, founders, investors, C-suite executives and industry experts across biotechnology, medical devices, pharmaceuticals, healthcare technology and the broader life sciences sector. IBN will leverage its article syndication, press release distribution and multibrand social media outreach, including more than 5,000 strategic syndication partners and 70-plus IBN brands, to expand conference visibility and highlight event sponsors, presenting companies and key industry discussions.

Ivanhoe Electric, a mineral exploration and extraction firm, may soon secure $1.1 billion in debt financing from the U.S. Export-Import Bank for the development of its Santa Cruz copper project in Arizona. The project is located roughly 65 kilometers southeast of Phoenix and is expected to become one of the first major new copper mines in the U.S. in nearly two decades. This comes as demand for the red metal continues to rise globally.

Driver-assistance technology has become one of the clearest signals of how far electric vehicles have advanced, and it is one of five features worth checking before buying an EV. Depending on the electric car, that can include automatic braking, lane-keeping help, blind-spot alerts, and cameras or radar that watch the road around the car.

mRNA vaccines and therapies have had a profound effect on the way various diseases, including infectious diseases like Covid-19, are treated. Scientists are working to improve how these treatments can be leveraged even more, and a research team has made a discovery that could introduce an improved mRNA platform through which vaccines and other treatments for cancer, infectious diseases and autoimmune conditions can be delivered more efficiently using lower doses than has been the norm.

When Fei Zhaojun’s manager asked whether AI might soon take over programming roles, the question sounded hypothetical. Within a fortnight, Fei was among 160 employees dismissed from a Beijing software company.

On Monday, prosecutors in Taiwan charged nine individuals with offences linked to the illegal export of high-end AI equipment to mainland China. The accused include two people that work with Super Micro and one that works with Nvidia. This case marks another flashpoint in the technology rivalry between Beijing and Washington.

Britain’s exhausted North Sea oil and gas fields may have a second act as vast underground hydrogen tanks. New research published in the journal Applied Energy found that depleted fields across the North Sea could hold roughly 3,659 terawatt-hours of hydrogen, enough to cover the country’s expected power use for over seven full years by 2040.

Russia’s central bank is making it easier for individuals to become qualified investors as the country prepares to introduce a regulated cryptocurrency market.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.

Wrap Technologies (NASDAQ: WRAP) announced its placement in a NetworkNewsWire editorial titled “The Overlooked Layer Where Counter-Drone Investment Dollars Are Now Heading.” The editorial examines the evolving counter-drone defense market and the growing importance of sensing technology alongside directed-energy interception. It highlights Wrap’s efforts to establish a position in this area through an exclusive U.S. and NATO license to physics-based sensing technology paired with laser directed-energy interception through an expanded partnership with Israeli firm Frenel Imaging. The technologies are part of WrapShield(TM), the company’s open architecture aimed at Department of War force protection, DHS border security, critical infrastructure and tactical law enforcement markets.

AZIO AI Holdings (NASDAQ: AZIO) was featured in a NetworkNewsAudio Audio Press Release titled “Inside the Multibillion-Dollar Race to Build the AI Economy’s Physical Backbone.” The audio release examines the concept of deployed GPU clusters as long-term, revenue-generating infrastructure and highlights AZIO’s integrated approach spanning GPU and compute-system sales, energy-backed hosting infrastructure and company-operated computing workloads. The model is designed to enable AZIO to capture value from both computing equipment and the physical infrastructure supporting its productive use over time.

AZIO AI Holdings (NASDAQ: AZIO) was featured in a NetworkNewsAudio Audio Press Release titled “Inside the Multibillion-Dollar Race to Build the AI Economy’s Physical Backbone.” The audio release examines the concept of deployed GPU clusters as long-term, revenue-generating infrastructure and highlights AZIO’s integrated approach spanning GPU and compute-system sales, energy-backed hosting infrastructure and company-operated computing workloads. The model is designed to enable AZIO to capture value from both computing equipment and the physical infrastructure supporting its productive use over time.

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is gaining another indication of the scale that its SSi Mantra surgical robotic system can support in India, where more than 50 robotic procedures were performed in a single day at Mohak Bariatrics and Robotics in Indore.

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC cell-free cartilage repair implant along parallel U.S. clinical and European commercial tracks, with more than half of the 80-patient pivotal Phase III SAGE study enrolled and recruitment targeted for completion in the third quarter of 2026. The FDA-approved single-arm study uses a historical microfracture control dataset owned by Regentis, and the company reports that the first 40 enrolled patients closely match the historical control group in baseline characteristics. In Europe, where GelrinC already has CE Mark approval, Regentis is preparing for broader commercialization through surgeon training, an expanding network of Centers of Excellence and distributor development. The company also received approval for a next-generation solvent-free manufacturing process that it says increases production yield by approximately 400%, potentially supporting commercial-scale supply while reducing costs and improving safety.

Disseminated on behalf of Xali Gold Corp. (TSX.V: XGC) and may include paid advertising.

American Gene Technologies (“AGT”), a Rockville, Maryland-based clinical-stage biotechnology company, will participate at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference taking place Sept. 9–10, 2026, in New York City. President Dr. Drew Palin is scheduled to deliver an investor presentation and meet one-on-one with investors. Dr. Palin’s presentation is slated for 11:30 a.m. ET on Sept. 10 at The Westin New York Grand Central. According to the announcement, the company is developing AGT103-T, a novel, one-time, gene-modified T-cell therapy that has demonstrated elimination of intact HIV reservoirs in humans.

Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its strengthened position among OTC-listed companies through consistent financial growth, timely reporting, vertical integration, prudent capital allocation, and ownership of hard real estate assets. Revenue increased to $35.7 million in FY2026 from $33.1 million in FY2025 and $11.95 million in FY2024, while gross profit rose to $25.5 million from $24.3 million and $7.8 million. The company attributes this progress to strategic investments and acquisitions made without adding debt, particularly its purchase of Avenvi, a real estate company whose 13-property portfolio includes the Texas property housing ETST’s Mister Meds pharmacy. Avenvi also provides financial services and manages real estate development and investment activities, giving ETST an additional asset-based component that complements its healthcare, pharmacy, and telemedicine operations.